
Keywords: TAC; tacrolimus; CLO; clobetasol; NLC; nanostructured lipid carriers; C; chitosan oligosaccharide; EPR; electron paramagnetic resonance spectroscopy; SC; stratum corneum; RS; remaining skin; Clobetasol; Tacrolimus; Nanostructured lipid carriers; Skin perm